Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Concerns Over the Construction of the Largest Animal Cloning Center in China

Jan 31, 2026 January 31, 2026 2 min read 📰 Radio Farda
📋 Key Takeaway

A new animal cloning center in China, set to produce over a million calves annually, has sparked ethical concerns among social media users. The project involves Chinese and Korean companies and aims to breed animals for commercial sale. This development raises significant ethical questions regarding cloning practices.

🔍 Quick Context Guide
💡 Bottom Line: The construction of this cloning center raises significant ethical questions about animal cloning and its implications for biotechnology.

👥 Key Players

Boyu Life MENTIONED
Chinese company constructing the cloning center
"Significant player in China's biotechnology sector, influencing animal breeding practices."
Suwon Biotech MENTIONED
Korean company collaborating on the project
"Known for its controversial history in cloning, impacting perceptions of ethical biotechnology."
Shou Xiaochun MENTIONED
Executive director of Boyu Life
"Key figure in promoting and overseeing the cloning center's operations."

📰 What Happened

A new animal cloning center in Tianjin, China, is set to produce over one million cloned calves annually, alongside other animals. This initiative has sparked ethical concerns among social media users regarding cloning practices.

  • The center will have an initial capacity of 100,000 calf embryos per year, eventually increasing to over one million.
  • The project involves a significant investment of 200 million yuan (approximately 31 million dollars).

💡 Why It Matters

🇮🇷 For Iran: Iran may observe these developments to gauge advancements in biotechnology, which could influence its own agricultural and scientific policies.
🌍 Regional: The cloning center could set a precedent in the region for biotechnology practices, raising ethical debates.
🌐 International: International stakeholders may scrutinize China's cloning practices, impacting global biotechnology regulations and ethical standards.

📚 Background

Animal cloning involves creating genetically identical copies of animals, which raises ethical and welfare concerns. This center aims to commercialize cloning for agricultural and law enforcement purposes.

Biotechnology ethics Animal welfare
📡 Source: NEUTRAL
📊 Confidence: 70%
The article cites reputable sources like Xinhua and Agence France-Presse, providing a balanced view of the situation.

The construction of the largest animal cloning center in China has raised concerns among a group of social media users. According to Xinhua, this center is set to produce dogs, horses, and over one million calves annually through cloning methods. In this context, Agence France-Presse reported that this center will be built by the Chinese company 'Boyu Life' and the Korean company 'Suwon Biotech' in northern Tianjin, China. 'Shou Xiaochun', the executive director of the Chinese company, stated that the center will begin its activities next year with an initial capacity of 100,000 calf embryos per year, which will eventually increase to over one million. He added that 200 million yuan (approximately 31 million dollars) will be invested in this project, which includes laboratories and a gene bank. The center is expected to breed racehorses and police dogs to be sold in the free market. The Korean company participating in this project claimed in 2004 to have produced the first cloned human embryo. The director of this company was hailed as a national hero but was accused in 2006 of fraud and ignoring ethical considerations in its research. The Korean company has posted a list of instructions on its website telling customers how to clone a deceased pet dog. A group of social media users has questioned the production of cloned animal meats, with some deeming these cloning practices unethical.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →